Upexi, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a UPXI research report →
Range $2 – $8
Price Chart
About the company
Upexi, Inc. engages in the development, manufacture, and distribution of consumer products. It offers nail grinder and healthy all-natural pet supplements under the LuckyTail brand; energy solutions under the PRAX brand; functional mushrooms under the Cure Mushrooms brand; cannabinoid under the Moonwlkr brand; and gummies and other products under the Gumi Labs brand name.
- CEO
- Allan Marshall
- IPO
- 2021
- Employees
- 59
- HQ
- Tampa, FL, US
Get TickerSpark's AI analysis on UPXI
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $66.92M
- P/E
- -0.25
- PEG
- -0.01
- P/S
- 2.56
- P/B
- -1.15
- EV/EBITDA
- -1.41
- Div Yield
- 0.00%
- Gross Margin
- 86.04%
- Op Margin
- 182.60%
- Net Margin
- -874.01%
- ROE
- -306.96%
- ROIC
- 25.00%
Latest fiscal year · YoY change
- Revenue
- $15.81M-39.2%
- Gross Profit
- $10.87M-15.3%
- Op Income
- $-12,499,752
- Net Income
- $-13,684,209+42.2%
- EPS
- $-1.73+92.8%
- OCF Growth
- -8208.6%
- FCF Growth
- -752.2%
- 52W High
- $9.12
- 52W Low
- $0.54
- 50D MA
- $0.84
- 200D MA
- $1.47
- Beta
- -0.24
- RSI (14)
- 59
- Avg Volume
- 1.78M
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Upexi said quarter results were pressured by the Solana bear market, but management emphasized share buybacks, capital raises, cost cuts, and staking/yield initiatives to make the treasury more self-sustaining.· May 12, 2026
- Solana price weakness and lower valuation multiples hurt the stock and drove a large unrealized loss.
- Management repurchased about 2.5 million shares for roughly $2 million and also issued a $36 million in-kind convertible note plus a $7 million equity-plus-warrants deal.
- The company says expenses are being reset through headcount reductions, outsourcing brand operations, and planned lease expirations.
- Staking revenue was roughly 35,000 tokens, and management said native staking yield was just below 7%.
- The company is exploring higher-yield strategies off-chain and believes it can move toward cash-flow neutrality as debt costs decline.
Fiscal third quarter 2026 total revenue was $4.6 million, up from $3.2 million in the prior-year quarter. Net loss for the quarter was approximately $109 million, or $1.67 per share, including $92.3 million of unrealized loss on digital assets. For the 9 months ended March 31, 2026, total revenue was approximately $21.8 million versus $11.5 million a year earlier; digital asset revenue was approximately $14.7 million; direct treasury expenses were approximately $8.6 million; and the company recorded an unrealized loss on digital assets of approximately $178.8 million. As of March 31, the company had approximately $3.5 million in cash, $2.5 million Solana tokens, $1.4 million liquid, and 1 million tokens locked. Management expects ongoing cash expenses to be less than staking revenue by July 1, assuming continued 6% to 7% staking yield, and expects to reduce short-term treasury debt interest, currently described as $500-plus thousand per month, over the next three months.
Allan Marshall framed the quarter as difficult because of the decline in Solana price and crypto valuation multiples, but said Upexi responded proactively rather than waiting for the market to improve. He highlighted three priorities: intelligent capital issuance, expense reduction, and yield generation. Marshall said the company aims to have the lowest expense base among Solana treasury peers and is pursuing higher-yield strategies using traditional Wall Street instruments off-chain.
Andrew Norstrud said staking generated approximately 35,000 tokens, and the company had about $3.5 million of cash, $2.5 million Solana tokens, $1.4 million liquid, and 1 million locked tokens at March 31. He said short-term debt was reduced by approximately $7.6 million, including $5.4 million of short-term treasury debt, and that employee count was reduced to 10. Norstrud also cited approximately $14.7 million of digital asset revenue for the 9 months ended March 31, 2026, about $8.6 million of direct treasury expenses, and an unrealized loss on digital assets of approximately $178.8 million. He said the company expects staking rewards to keep rising and that it is working to bring ongoing cash expenses below staking revenue.
Analysts focused on the native staking yield, the path to a self-sustaining treasury, M&A, NAV math, and capital allocation. Management said native staking yield is just below 7%, while locked tokens can generate closer to double that, and that any M&A or higher-yield strategy would need to clear those returns. On valuation, Brian Rudick explained that Upexi manages to a fully loaded mNAV assumption that includes expected conversion of in-kind notes and backing shares, which is why the company views the metric differently from a simple EV-to-NAV calculation. On cash generation, Allan Marshall said excess cash would likely go toward either buying more Solana or repurchasing stock, and that initial allocations to higher-yield strategies could be around $25 million or $50 million.
Management believes the company is now operating with a leaner cost base and could reach or approach cash-flow neutrality as lease exits and debt refinancings reduce monthly interest burden. The team also argued that Solana fundamentals remain strong, with stablecoins, tokenization, and agentic payments providing longer-term demand drivers. They said capital market actions have already been accretive to Solana per share and could continue to be so.
The quarter was heavily impacted by Solana’s price decline and the resulting $92.3 million unrealized loss, and management acknowledged that the business remains highly sensitive to token prices and valuation multiples. The company still carries significant short-term treasury debt and said monthly interest is currently $500-plus thousand, while the higher-yield strategy is still in exploration rather than proven. Management also noted that market conditions are weak enough that they are waiting to see what opportunities become available for M&A or yield enhancement.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 82.3%
- Shares Outstanding
- 73.45M
- Float Shares
- 60.44M
of shares held by institutions
70 13F filers
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Vanguard Group Inc | 710.74K | 0 |
| Synovus Financial Corp | 25.10K | ▲ 25.10K |
| Cibc Private Wealth Group, LLC | 4.00K | ▲ 4.00K |
Held by 21 ETFs
Biggest fund positions in UPXI by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jul 3, 26 | Salkind Gene | other | 100,000 |
| Jul 3, 26 | Dugan Lawrence | other | 100,000 |
| Jul 3, 26 | Rudick Brian Benjamin | other | 400,000 |
| Jul 3, 26 | MARSHALL ALLAN | other | 2,000,000 |
| Jul 3, 26 | Norstrud Andrew James | other | 400,000 |
| Dec 23, 25 | MARSHALL ALLAN | buy | 50,000 |
| Dec 16, 25 | MARSHALL ALLAN | buy | 50,000 |
| Dec 15, 25 | MARSHALL ALLAN | buy | 100,000 |
| Oct 1, 25 | MARSHALL ALLAN | other | 1,600,000 |
| Nov 20, 25 | Salkind Gene | buy | 50,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our UPXI coverage
Recent articles, reports, and earnings notes.
No research on UPXI yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate UPXI report →Upexi Partners with Blueprint to Stake Solana Treasury Assets
globenewswire.com · Jun 30
Upexi Added to the Russell Microcap® Index
globenewswire.com · Jun 26
Upexi, Inc. Announces Pricing of ~$19.5 Million Private Placement of Common Stock
globenewswire.com · Jun 22
Upexi Q3 Earnings Call Highlights
marketbeat.com · May 12
Upexi, Inc. (UPXI) Q3 2026 Earnings Call Transcript
seekingalpha.com · May 12
Upexi Reports Fiscal Third Quarter 2026 Financial Results
globenewswire.com · May 12
Upexi to Present at the LD Micro Invitational XVI Conference on May 17-19
globenewswire.com · May 7
Upexi Provides Periodic Update to its Share Repurchase Program
globenewswire.com · May 6
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.